Now, despite playing no formal role in the battle between Pfizer and Starboard, Guggenheim has found itself in the crossfire of one of the messiest activist campaigns in recent Wall Street memory.
Pfizer Inc. and Albert Bourla got the upper hand in an early skirmish against Starboard Value LP — but the drugmaker and its ...
The activist investment firm Starboard Value has launched a proxy fight again Pfizer, questioning the company’s management ...
JPMorgan Chase, Wells Fargo and BlackRock reported strong quarterly results to kick off earnings season, but concerns linger ...
Pfizer is facing a messy showdown this week after an outside bid to revive the company’s post-Covid share plunge took an ...
In another twist to the tale of Starboard Value's push for change at Pfizer, the activist investor has claimed former ...
Former Pfizer CEO Ian Read and former CFO Frank D’Amelio announced their withdrawal from Starboard Value’s activist campaign ...
Investor's Business Daily on MSN6d
Pfizer Skids After Former Execs Flip On Starboard; Activist Investor Says They Were CoercedPfizer stock skidded Thursday after former executives Ian Read and Frank D'Amelio said they are siding with the drugmaker in its battle with activist investor Starboard Value.Please watch the video at ...
Key Takeaways Two former Pfizer executives published a statement saying they support management as it gets pressured for ...
In a letter to Pfizer’s board, the activist investor claimed former CEO Ian Read and CFO Frank D’Amelio were pressured to abandon a Starboard-led attempt to change the company’s direction.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback